$ 16.99See all
Ginos - biologically active substances of Ginkgo biloba leaf extract (standardized to a content of 9.6 mg and 2.4 mg ginkgoflavonoglikozidov terpenlaktonov (ginkgolides and bilobalide), 40 mg of extract) help to strengthen and improve the elasticity of the vascular wall, improve the rheological properties of blood and thus improves microcirculation, supply of the brain and peripheral tissues of oxygen and glucose. The drug has cerebroprotective properties. Decreases vascular permeability (decongestant effect - both on the level of the brain and in the periphery). The drug normalizes metabolism in cells, prevents the aggregation of red blood cells, inhibits platelet activating factor. Lets increase blood fibrinolytic activity. It prevents the formation of free radicals and peroxidation of cell membrane lipids. It has a dose-dependent regulating effect on the vascular system, expanding small arteries, increases the tone of veins, regulates blood circulation in blood vessels. The preparation increases the stability of the whole body and particularly brain tissue to hypoxia, traumatic or inhibits the development of toxic cerebral edema.
Precautions: acute ischemic stroke; hypotension.
Do not exceed the recommended dose.
Improving the condition usually manifests within 1 month after initiation of treatment.
In a sudden decrease or loss of hearing should immediately seek medical help. Medical consultation is also needed at frequent dizziness and tinnitus.
It is not recommended to take the drug Ginos together with alcoholic beverages.
Possible allergic reactions (rash, pruritus), gastrointestinal disorders (dyspepsia), headache, decreased blood clotting.
There are reports of internal bleeding observed after long-term use of drugs based on ginkgo biloba.
In the case of the above adverse reactions the drug should stop and consult a doctor.
The inside is not liquid, squeezed small amounts of water. Take in the morning, noon and night, regardless of the meal.
If your doctor has not recommended a different dosing regimen, you must adhere to the following recommendations on the admission of the drug.
For the symptomatic treatment of disorders of cerebral circulation: Table 1-2. 3 times a day. Duration of treatment - not less than 8 weeks.
When violations of the peripheral circulation: 1 table. 3 times a day. Duration of treatment - 6-8 weeks.
When neurosensory disorders: 1 tablet. 3 times a day. Duration of treatment - 6-8 weeks.
Carrying out of repeated courses of treatment may, after consultation with the doctor.
If the drug was passed or adopted in insufficient quantities, follow its reception should be performed as specified in this manual without any changes.
Important notice- the outer box design may vary before prior notice!